Assignee profile:

CSL LIMITED

City:

Melbourne

Country:

Australia

Published Applications:

10

Last publication date:

2025-10-16

Patent Grants:

5

Last grant date:

2025-04-01

Top Inventors for applications by CSL LIMITED

These are the the leading inventors for applications assigned to CSL LIMITED:

Recent patent applications by CSL LIMITED

CSL LIMITED based in Melbourne, AU has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-10-16
US20250320300A1
Chemistry; metallurgy

METHODS OF REDUCING OR HINDERING DEVELOPMENT OF ISCHEMIA-REPERFUSION INJURY DUE TO KIDNEY TRANSPLANTATION WITH AN ANTIBODY THAT INHIBITS GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) SIGNALING

#2 | 2025-04-17
US20250122295A1
Chemistry; metallurgy

METHOD OF TREATMENT OF PHILADELPHIA CHROMOSOME POSITIVE LEUKEMIA

#3 | 2025-03-27
US20250099537A1
Human necessities

Reconstituted HDL Formulation

#4 | 2025-02-13
US20250051462A1
Chemistry; metallurgy

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

#5 | 2024-06-27
US20240207357A1
Human necessities

RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION

#6 | 2023-09-07 ✅ Patent 12,264,202 granted on 2025-04-01
US20230279129A1
Chemistry; metallurgy

Methods of reducing or hindering development of ischemia-reperfusion injury due to kidney transplantation with an antibody that inhibits granulocyte-colony stimulating factor (G-CSF) signaling

#7 | 2023-05-11 ✅ Patent 11,957,731 granted on 2024-04-16
US20230142696A1
Human necessities

Reconstituted HDL formulation

#8 | 2021-10-21 ✅ Patent 11,840,573 granted on 2023-12-12
US20210324091A1
Chemistry; metallurgy

CD131 binding proteins and uses thereof

#9 | 2021-01-14 ✅ Patent 12,071,484 granted on 2024-08-27
US20210009701A1
Chemistry; metallurgy

Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein

#10 | 2021-01-14 ✅ Patent 12,281,160 granted on 2025-04-22
US20210009677A1
Chemistry; metallurgy

Method of treating asthma

Also check out CSL LIMITED's (Melbourne, Australia) applicant profile with 10 patent applications submitted.

AssigneeID:

607993 ⎘